ãã¥ãŒã«ããŸãŒã« ã¬ãã¥ãŒ ãš åºå åè§£: ç ç©¶ ã® åã ã® èŠæ¹
ãã¥ãŒããŸãŒã« ãã㪠販売 æçŽ ã® ãªãŒããã³ã° 60 ç§ ã¯ åå åå äŸ¡æ Œ ã«ããŽãªãŒ è«æ± ã§ã¯ãªã 女æ§ã® å§ãŸãã§ã 67 æ³ éè· ã ã å åŠç
8,226+
Videos & Ads
+50-100
Fresh Daily
$29.90
Per Month
Full Access
12.5 TB database · 72+ niches · 28 min read
Nervizolãããªè²©å£²æžç°¡ã®éå¹60ç§ã¯,補å説æ,äŸ¡æ Œ,ã«ããŽãªãŒè«æ±ããå§ãŸãããã§ã¯ãããŸãã.ã«ãªãã©ã«ãã¢ã®67æ³ã®éè·ããå æåž«ã®å¥³æ§ããå§ãŸããŸã.圌女ã¯ãã§ã«ç¥çµçã修埩ããããš3000ãã«ãè²»ãã,17å倱æããŸãã.圌女ã¯ã¬ããã³ãã³,ã©ã€ãªã«,3ã€ã®ç¥çµãããã¯,TENSãŠããã,ã¢ãã¥ãã³ãã¥ã¢,CBDãªã€ã«,300ãã«ã®èµ€å€ç·ã©ã€ãè£ çœ®ã詊ããŸãã.ãããã®ã¢ã€ãã ã®ããããã¯,åãéã«æ²¿ã£ãèŠèŽè ã®èªèç¹ã§ãããã,æå³çã«åœåãããŠããŸã.VSLã¯ãããã§éãããã§ã¯ãããŸãã.ããã¯é¡ã§éããŸã.ãã®ãªããªãã¯ãªåãã§ã.ãã®æŽå²ãæãå€ãèŠèŽè ã®å°å³ã«å»ãŸããŠãããã£ã©ã¯ã¿ãŒã玹ä»ã,æãä¿¡é Œæ§ã®é«ãã³ããŒã»ã¬ã¹ããŒã«ãå±éããããŒã ã§ã. 補åèªäœã¯8ã©ããšããäŒç€Ÿã§è£œé ããã,Nervizolãšããåã§è²©å£²ãããŠãã,åœæ¥çšãã°ãã·ãŠã ã¯ãã©ã€ããªã€ã«ã§ãã.äžå¿äž»åŒµã¯,åšèŸºç¥çµç ç,æ°çŸäžãã®ã¢ã¡ãªã«äººãèŠãããçã,åºã,,麻çºã¯,åºæ¬çã«ãã°ãã·ãŠã äžè¶³ã®åé¡ã§ãã,åŸæ¥ã®æ²»çã倱æããçç±ã¯ç¥çµæå·ã®çç©åŠã§ã¯ãªã,ã»ãšãã©ã®ãµããªã¡ã³ãã®é éã¡ã«ããºã ã§ãã.é å€ãšã¯ãªãŒã ã¯,äžé©åãªååãµã€ãºã§ééã£ã圢åŒã®ãã°ãã·ãŠã ã䜿çšã,ééã£ã衚é¢ããåžåãããŸã.Nervizolã®çãã¯,è¶³ã®è¶³åºãéããŠç®èã®ééã,è¬å€çŽã®ãã°ãã·ãŠã ã¯ãã©ã€ãã䜿çšã,ç®èå£ãéã£ãŠç¥çµã«çŽæ¥å°éããã»ã©å°ããã§ã. è¬å€ã®ã¡ã«ããºã ã¯,ç¥çµã®è¡šé¢ããåžåããã. è¬å€ã®åå¿ã¯,ç¥çµã®è¡šé¢ããåžåããã. è¬å€ã®äœçšã¯,ç¥çµã®è¡šé¢ããåžåããã. è¬å€ã®äœçšã¯,ç¥çµã®è¡šé¢ããåžåããã. ããã¯ããŒã±ãã£ã³ã°ãæšé²ããæç®ã§ãã,ã€ãŸã補åã䞻匵ããå 容ãš,ãããã®äž»åŒµãã©ã®ããã«ããã±ãŒãžåãã販売ããããã«é¢äžãããã®ã§ãã.Nervizolã®åŸãã«ããVSLã¯,èµ·æºç©èª,æªåœ¹ã®æ çµ,å ç©ãããæš©åšä¿¡å·,éå±€äŸ¡æ Œèšå®,çšæååŠ,ããã³äžå·§åŠãªé£ç¶ã§èšŒèšã®ã«ã¹ã«ãŒãã§ãã.補åãçŽæã«å¿ããããšã¯,販売æžç°¡ãããŸãæ§ç¯ãããŠãããã©ãããšåé¢ããåé¡ã§ãã,äž¡æ¹ã®è³ªåã¯æ éã«æ±ãããã«å€ãã.äž¡æ¹ã®ç³žãåæã«ä¿æããããšãã調æ». 詳现ã¯,ãã®èšäºã®è©³çްãæããã«ãã. éè¡ ãã¥ãŒããŸãŒã«ãšã¯äœã? Nervizolã¯,äž»ã«ãã°ãã·ãŠã ã¯ããªããäžå¿ã«è£œæããã,8ã©ããåäœ,åäœ,ããã³6ç¶ã®æ§æã§è²©å£²ãã,ããã«ã«ãªãªã€ã«ãµããªã¡ã³ãã§ãã.ããã¯,è¬å€ã®åªããè¬å¹æ§ã䞻匵ããã®ã§ã¯ãªã,åªããæäžçµè·¯ã䞻匵ããããšã§,壿ãã°ãã·ãŠã ãµããªã¡ã³ããšåŠæ¹ç¥çµç è¬ã®äž¡æ¹ã«çŽæ¥ç代æ¿ãšããŠäœçœ®ã¥ããããŠãã.補åã¯ç®è,ç¹ã«è¶³è¶³åºã«é©çšãã,æ¯æ¥äœ¿çšããããšãæå³ããŠããŸã.ãã®ç®çã¯,å€åŽç¥çµç ççç¶ã®ç·©åã§ã:çã¿ãçã,ã¿,麻çº,ããã³ç¡ç é害ãåŒãèµ·ãããããã®çç¶. ãã©ãŒãããã¯ããŒã±ãã£ã³ã°ã®è°è«ã«æ§é çã«éèŠã§ãã.Nervizolã¯é å€ã§ã¯ãªã,ããã«ã«ãªã€ã«ã§ãããã,VSLã¯æ¶ååšåžååé¡ãåé¿ã,èŠèŽè ã詊ãããã¹ãŠã®ä»¥åã®ãµããªã¡ã³ãã®äžå€®çãªå€±æãšããŠç¢ºç«ããã®ã«çžåœãªæéãè²»ãããŠããŸã.ããã¯æç§æž ã«ããŽãªãŒãšã³ããªãŒãã€ã³ãããã¥ã¢ãã«ã§ã.補åã¯,ãã®å 容ã«ãã£ãŠå®çŸ©ããã,äŒçµ±çãªè£œåã倱æããå Žæã«ãã£ãŠå®çŸ©ãããŸã.Nervizolã¯VSLèªèº«ãæ°ãã«æ§ç¯ããåé¡ã«å¯Ÿããè«ççãªçãã«ãªããŸã.VSLããã¬ãŒã ãèšå®ããããã«,ã¿ãŒã²ãããŠãŒã¶ãŒã¯,çŽ55æ³ãã75æ³ãŸã§ã®æäººã§ã. 補åèåŸã«ãããã©ã³ãã¯,8 Labsã¯,VSLã§æåã¯èªãæãšææºããããšãèºèºããå°ããª,ååã«åºã¥ãç¬ç«ããäŒæ¥ãšããŠç޹ä»ãããŠããŸã.ãã®ãã¬ãŒã ã¯æå³çã«ãããŸã:ããã¯8 LabsãQuality-Focusedã§ã¯ãªã,å©çã«é§åããããã®ãšããŠäœçœ®ã¥ããŠããŸã.ããã¯VSLã®ä»¥åã®äž»åŒµã«çãããã,ã»ãšãã©ã®ãµããªã¡ã³ãäŒæ¥ã¯çµæãããããŒãŒãžã³ã«èå³ããããŸã.8 Labsã¯æ¬åœã«å°ããªç¬ç«ããäºæ¥ãªã®ã,ãŸãã¯èŠªåãªããŒãœãã®äžã§éå¶ããçŽæ¥å¿çãµããªã¡ã³ããã©ã³ããªã®ãã¯,VSLããã®ã¿ç¢ºèªã§ããŸãã.ããã,ãã¬ãŒã ã¯èšç®ãããä¿¡é Œæ§ç¯è£ 眮ã§ã. éè¡ ç®æšãšãªãåé¡ åšçžç¥çµç ã¯ãããç ã§ã¯ãªã.åœç«ç¥çµçŸæ£ãšè³åäžç ç©¶æ (National Institute of Neurological Disorders and Stroke) ã¯,ã¢ã¡ãªã«ã§ã¯2000äžäººä»¥äžã®äººã ãåšçžç¥çµç ã®äœããã®åœ¢æ ãæããŠãããšæšå®ããŠãã,ç³å°¿ç ç¥çµç ã¯æå€§ã®åäžã®ãµãã°ã«ãŒãã§ãã.ã¢ã¡ãªã«ç³å°¿ç åäŒã¯,ç³å°¿ç æ£è ã®50%ãã70%ã®éãäžçéã«ç¥çµç ãçºçãããšææããŠãã.ãããã®æ°åã¯,ç¥çµç ãæ¶è²»è ã®å¥åº·ã«ãããæå€§ã®æ¬ æã®çã¿ã®åžå Žã®äžã€ã«ããŠããŸã.ãããŠ,ãã®ç¶æ ãã¿ãŒã²ãããšããVSLã,ä¿¡é Œæ§ã®ãã䞻匵ãããŠã,å¯èŠæ§ãæŒãä»ããã«"æ°åäººã®æ£è ã«éããå¯èœæ§ãããçç±ã説æããŸã.åæ¥çæ©äŒã¯çŸå®çã§,ãã®èåŸã«ããèŠãã¿ã¯çŸå®çã§ã. VSLã¯,ãã®åé¡ãåãªã身äœçãªçã¿ã§ã¯ãªã,çãŸããçæŽ»ãšããŠæåããŠãã.æåã®ãã£ã©ã¯ã¿ãŒã§ããã¹ãŒã¶ã³æ°ã¯,å«ãã¡ãåç©åã«é£ããŠè¡ãããã«ãããããèµ·ããããªã.第äºåœ¹ã§ãããªã³ãã¯,èªãæã®åŠ»ãæ¶ãæµããŠåŒã³ãŸã.圌女ã®å£°ã"æ³£ãéãå²ã£ãŠãã"ãš,å®å šãªåªåã䌎ã人çãæåããŠããŸã.åäŸãã¡ãè²ãŠ,æ°å幎ãã®æè².ããã¯çã¿ãšäŸåã«çž®å°ãããŠããŸã.ãã®ææ çæ§ç¯ã¯,粟å¯ã§ã.ããã¯ç¥çµäŒå°é床ã®ç©ççãªæèŠã ãã§ãªã,ãã®èº«åã®è åšãã¿ãŒã²ãããšããŠããŸã.çç£æ§,è²¢ç®,ãããŠå®¶æã®ããã«åºãããèœåãéããŠèªå°å¿ãå®çŸ©ããäžä»£ã«ãšã£ãŠ,VSLã®ç¥çµäŒå°é床ãå°å³å±æ©ãšããŠæåããããšã¯,ç¥çµäŒå°é床ã®èšåºç説æãããã¯ããã«é¿ããããã§ããã. 粟ç¥äŒå°é床ã¯,ç¥çµäŒå°é床ãäžå¿ã«æåãããã®ã§ã. VSLã¯å»çæ©é¢ãè§£æ±ºæ¹æ³ã§ã¯ãªãåé¡ã®äžéšãšããŠäœçœ®ã¥ããŠããŸã. Gabapentinã®ãããªåŠæ¹è¬ã¯,æ£è ã®1人ã"èªåã®å«ã®ååãå¿ã" assez èªç¥é§ãåŒãèµ·ãããŠãããšèª¬æãããŠããŸã.ç¥çµãããã¯ã¯,çã¿ãæªåããããšèª¬æãããŠããŸã.æè¡ã¯é«äŸ¡ãã€å±éºã®äž¡æ¹ã§å°å ¥ãããŠããŸã.ãã® åœæµã®æ çµ;äŒçµ±çãªçŽæ¥å¿çæ§é ã¯,çŽç²ã«æäœçã§ã¯ãããŸãã.å»åŠæç®ã§ææžåãããçã®æ£è ã®äžæºãåæ ããŠããŸã. 2017幎ã®"çã¿ã®å»åŠ"ã®ã·ã¹ãã ã¬ãã¥ãŒã§ã¯,ç¥çµç æ£è ã®åæ°æªæºãå©çšå¯èœãªè¬å€çæ³ããææçŸ©ãªçã¿ã軜æžããããšãçºèŠããŠããŸã. VSLã¯,å®éã®åé¡ãåãå ¥ã,ææ çã«åŒ·åã,ãã«ãŽã£ãŸã«ãå°å ¥ããåã«ããããä»£æ¿ææ®µãå©çšããŠäžåæ ŒãããŸã. VSLãåºã«ããæ é€çŽ äžè¶³ã®è§åºŠã¯,ãã°ãã·ãŠã äžè¶³ãç¥çµçã®äž»èŠãªèŠå ã§ãããšããä»çµã¿ã¯,蚌æ ãæ¯æãããããç¢ºå®æ§ãé«ããã®ãšããŠæç€ºãããŠããã,æé ãããŠããªã.è€æ°ã®ç ç©¶è ãåæããåœç«å¥åº·æ 逿€æ»èª¿æ» (NHANES) ã®ããŒã¿ã¯,å€ãã®ç±³åœæäººã®å²åã,䜿çšãããéçå€ã«å¿ããŠ45%ãã75%以äžã«åã¶æšå®å€ã,æšå¥šãããã¬ãã«ãäžåã£ãŠããããšã瀺ããŠããŸã.ãã°ãã·ãŠã äžè¶³ãšç¥çµæ©èœã®éã®é¢é£æ§ã¯,çã«ç¢ºç«ãããŠããŸã.è£çµŠãšç¥çµçã®éã®ç¹å®ã®å æçãª àš°àšŸàš¹ã¯,ç§åŠãããªãææ§ã«ãªãå Žæã§ã. è£çµŠãšç¥çµçã®æ²»çã¯,ç§åŠã®æ²»çã«éåžžã«å°é£ã§ã. è£çµŠãšç¥çµçã®æ²»çã¯,å€ãã®å Žå,éåžžã«å°é£ã§ã. è£çµŠãšç¥çµçã®æ²»çã¯,éåžžã«å°é£ã§ã. è£çµŠãšç¥çµçã®æ²»çã¯,éåžžã«å°é£ã§ã. è£çµŠãšç¥çµçã®æ²»çã¯,éåžžã«å°é£ã§ã. è£çµŠãšç¥çµçã®æ²»çã¯,éåžžã«å°é£ã§ã. è£çµŠãšç¥çµçã®æ²»çã¯,éåžžã«å°é£ã§ã. > ãã®ãããã®ä»ã®VSLãã©ã®ããã«ããããæ§æããŠããã®ãæ°ã«ãªãã?ç¶ããèªã. [ããã¯ã¹ã»ã¯ã·ã§ã³] (#ããã¯ã¹&ã¢ãã¢ã³ã°ã«) ãš [å¿çåŠåè§£] (#å¿ççè§Šçºãšèª¬åŸæŠè¡) äžã®éšåã§ã¯èª¬åŸæ§é ãè©³çŽ°ã«æ±ã£ãŠããŸã. éè¡ ãã¥ãŒããŸãŒã«è¬ã®åã VSLãé²ããä»çµã¿ã¯,çžäºã«çµ¡ã¿åã£ãŠãã2ã€ã®äž»åŒµã«åºã¥ããŠããŸã.äžã€ã¯,å€åŽç¥çµç ã¯,å®è³ªçã«ãã°ãã·ãŠã äžè¶³ã«ãã£ãŠåŒãèµ·ãããã.ãããŠäºã€ã¯,ç¥çµç®çã®ããã«ãã®æ¬ ä¹ãä¿®æ£ããå¯äžã®å¹æçãªæ¹æ³ã¯,è¶³ã®è¶³åºã«ãã°ãã·ãŠã ã¯ããªããç®èãééããŠé©çšããããšã§ã.æåã®äž»åŒµã¯,é©åºŠã«ç§åŠçæ¯æããã.äºã€ã¯,蚌æ ãå®å®ã,ããŒã±ãã£ã³ã°ã®æœåºãæãæ»æçã«ãªã. æ¬ é¥åé¡ã«ã€ããŠ:ãã°ãã·ãŠã ã¯ç¥çµäŒå°,ç¥çµçèäŒæ,ããã³çã¿ã®äžå€®æç¥ã«é¢äžããNMDAå容äœ,å容äœã®èŠå¶ã«èšéããã圹å²ãæãããŸã.ãã°ãã·ãŠã ã®æ¬ ä¹ç¶æ ã¯,ç¥çµåºæ¿æ§ãçã«é«ã,ããã€ãã®ç ç©¶ã«ãããš,éèå æäžãã°ãã·ãŠã ã¯èšåºç°å¢ã§ç¥çµçã軜æžããããšãå¯èœã§ãã (Crosby et al., Canadian Journal of Anesthesia, 2000; Tramer et al., åçš®). "IVãã°ãã·ãŠã ã¯æ¥æ§ç¥çµçãå©ããããšãã§ãã"ãã"ããã«ã«ãã°ãã·ãŠã ã®å¡©ååç©ãæ ¢æ§ç¥çµçãé転ããã"ãžã®è·³èºã¯å€§ãã.VSLã¯ã®ã£ãããèªèããã«ãããè¡ã.ããšã¯ãªããã¯ã¯"ç¥çµã¯1ã€ã³ããŸã§æ"ã«çŽç«ãã"ãšäž»åŒµãã.å®éã®ç§åŠã§ã¯,å®è³ªçã«åºç€ããã.ãã®ææžã§ã¯,ãã°ãã·ãŠã ã®åçèœåã¯çŽ1~3mmã«åã¶.ããã,ç¹å®ã®ç¥çµä¿®åŸ©æ¡ä»¶ã§ã¯,ç¥çµåçèœåã¯çºçããŠããªã. ææžã§ã¯,ãã°ãã·ãŠã ã®åçèœå㯠ç®èã¯èšèšçã«å¹æçãªéå£ã§ãã,ç®èã®è¡šé¢ã«å«ãŸãããã°ãã·ãŠã ãå€ç®æ§æäžã«ããææçŸ©ãªã·ã¹ãã åæäžã®èšŒæ ã¯æ··åããŠãã.ã°ãããŒ,ã¯ãŒããŒ,ãŽã©ãŒãã³,ãã¹ã¿ãŒãºã«ãã2017幎ã®ã¬ãã¥ãŒèšäºã§,éèª"Nutrients"ã§,åœæã®ãã°ãã·ãŠã 補åãåºã販売ãããŠããã,ç¹ã«å£è äžè¶³ã®ä¿®æ£ã®ããã«,ç®èã¯å¹æçãªéå£ã§ãã.VSLã¯,ç¥çµå¯åºŠãšè¡ç®¡æ¿åºŠã«ããè¶³ã®è¶³ã®åºéšãç¬ç¹ã«æå©ãªåžåæ§ãæã£ãŠãããšäž»åŒµããŠãã.ããã¯æ¹åæ§äž»åŒµãšããŠå¯èŠã§ãã (æ€ç©èã¯åããè¡ç®¡ç³»ãè±å¯ã§ãã),ããã,ãã®ç ç©¶ã§çºè¡šãããç¹å®ã® 87%ã®æžå°ã¯,ãã®ç¹å®ã®ç ç©¶ãæ€èšŒããèšåºç ç©¶ã§,ãã®ç¹å®ã®ããŒã¿ã«æ¯ã¹ãŠ,ç¹å®ã®æ°åãæ€èšŒãã3000人ã®ãã©ã³ãã£ã¢ãç¹å®ã«ç¹å®ãããèšåºè©Šéšã«ä»£ãã£ãŠç¹å®ã«ç¹å®ãããã¹ãã§ã¯ãªããšå ±åããŠãã. MSM (ã¡ãã«ç¡«ãã«ã¡ã¿ã³) ãšã¢ã«ãã«æåã«ã¯ç¬èªã®æ¯æŽæç®ããããŸã. ãžã£ãŒãã«ã»ãªãã»ãã€ã³ã»ãªãµãŒã (ãŠã·ã£ãšãã€ãã¥,2004) ã«æ²èŒãããç ç©¶ãå«ãããã€ãã®ã©ã³ãã åå¶åŸ¡è©Šéšã§ã¯,MSMãè»œåºŠã®æçæ§å¹æãæããããšã倿ããŸãã.ã¢ã«ãã«ã¯,çŸå Žã§åŸªç°ããµããŒãããç¹æ§ãèšé²ããŠããŸã.ç¥çµæšçããã©ã«ãšæçæ§ããã³åŸªç°è¬ãçµã¿åãããé æ¹è«çã¯,å šäœçãªæå¹æ§ã®äž»åŒµãå©çšå¯èœãªå¶åŸ¡ããã蚌æ ãããã¯ããã«å è¡ããŠãããšããŠã,äžè²«ããŠããŸã. éè¡ ## éèŠãªæåãšæå Nervizolã®é æ¹è«çã¯,ç¥çµæ é€,çç軜æž,åŸªç°æ¯æŽãçŽæ¥çµåããæç¥çµç ã¢ãã«ã«åŸããŸã. VSLã¯ãããç®çããäžã€ã®ã¡ã«ããºã ã¢ãããŒããšããŠæç€ºã,ããã¯,ç®èç³»å€çãªã³ã³ããã¹ãã«ãããåæåã®èšåºèšŒæ ãç°ãªãéçºæ®µéã«ããå Žåã§ã,ããã«ã«ç¥çµç 補åã®ããã®åççãªèšèšæ çµã¿ã§ãã. - ãã°ãã·ãŠã å¡©ååã¯,äž»èŠæŽ»æ§æåã§ãã,補åã®ã¡ã«ããºã äž»åŒµã®æ¯æ±ã§ãã.ãã°ãã·ãŠã å¡©åã¯,å¡©å圢åŒãšããŠæº¶è§£æ§ãé«ã,ãã°ãã·ãŠã é žåç©ãŸãã¯ãã°ãã·ãŠã ç¡«é ž (ãšããµã å¡©) ãšæ¯ã¹ãŠã€ãªã³ãµã€ãºãå°ãã.VSLã¯ããå®ã補åã«ãããæ¥çæšæºãšããŠæ£ããèå¥ãã.ããã€ãã®èšŒæ ã«ãããš,ãã°ãã·ãŠã å¡©åç©ã¯,ãã倧ããªåå圢æ ãããå€åŽã®ç®èå±€ã容æã«æµžéããããšãå¯èœã§ããã,ããã¯æ²»çç¥çµé éã«ç¿»èš³ãããçšåºŠã¯,掻çºãªç ç©¶äžã«æ®ã£ãŠãã.ç¥çµã«å°éããããã«å®å šã«è¡æ¶²ã暪æãããšãã䞻匵ã¯,æ©æ¢°çã«è峿·±ãã,åºçãããæç®ã§ã¯ååã«ç¢ºç«ãããŠããªã. - **MSM (ã¡ãã«ç¡«ãã«ã¡ã¿ã³) *ã¯,æçæ§ç¹æ§ã®ããææ©ç¡«é žååç©ã§ãã.Kim et al.ã«ããåç²,ã©ã³ãã åãããç ç©¶ã§ã¯ (骚é«çãšè»éªšç, 2006) ãMSMãé¢ç¯çã¿ã軜æžã,èº«äœæ©èœãæ¹åããããšã倿ãã.ç¹ã«VSLã®åŒçšã§åŒçšãããç¥çµççã®èšå·ã§ã¯,ç¥çµççã¯æ ¢æ§ç¥çµççã®éèŠãªåå ã§ãããšèªèãããŠãããã,çç©åŠççã«åççã§ãã. - ã¢ã«ãã« (Arnica montana) ã¯,å·,é¢ç¯ç,çèçã«åœå Žçã«äœ¿çšãããç¥ãããæ€ç©æ§æçè¬ã§ãã.ãã®ã¡ã«ããºã ã«ã¯,NS-κBçççµè·¯ãæå¶ããã»ã¹ãã¿ãŒãã³ä¹³ããŒã³ (ç¹ã«ãã¬ã³ã¢ã«ãªã³) ãå«ãŸãã.VSLã¯,ç¥çµãžã®é žçŽ äŸçµŠãæ¹åãã埪ç°åŒ·åå€ãšããŠã¢ã«ãã«ãæ§æãã.ããã¯,åœå Žäœ¿çšã§ç¥ãããŠããè¡ç®¡æ¡åŒµæ§ãšäžèŽããŠããã,ã»ãšãã©ã®å¶åŸ¡ãããç ç©¶ã¯ç¥çµç ãããçèéªšæ Œå¿çšã«çŠç¹ãåœãŠãŠããŸã. åžžèŠåé¡é ã«èšèŒãããŠãã"ç¥çµæ¯æŽæ€ç©"ã®äžã§ãã¿ãã³B6 (ããªããã·ã³) ãå«ãŸããŠããŸã.B6ã¯åšèŸºç¥çµæ©èœã«äžå¯æ¬ ã§ã.æ¬ ä¹çã¯æèŠç¥çµç ãåŒãèµ·ããã,è£çµŠã¯å€ãã®èšåºç°å¢ã«ãããæšæºç¥çµç 管çãããã³ã«ã®äžéšã§ã.ããã,éå°æåããB6ã¯ç¥çµç ãåŒãèµ·ããå¯èœæ§ããããŸã.VSLã¯,ãã®ãã¥ã¢ã³ã¹ã«å¯ŸåŠããŠããŸãã.ããã«ã«é æ¹ã§ååšããæ¿åºŠã§ã¯,B6æ¯æ§ã¯æžå¿µãããå¯èœæ§ã¯äœãã,ç®èçµç±çç©å©çšæ§ã¯å£ææäžããã確ç«ãããŠããªã. - ç¥çµæ¯æŽæ€ç© (æªæå®) ã¯FAQãšéå¹ã»ã¯ã·ã§ã³ã§äžè¬çã«åç §ãããŠããŸã.ãã®ç¹ã§ã¯ç¹æ§ãæ¬ ããŠããã®ã¯,軜床ã®éææ§ã®å·®ã§ã. Nervizolã®ãããªå³æ Œãªè²©å£²ãããé æ¹ã§ã¯,æåãå®å šã«å ¬éããããšã§å©çãåŸãããšãã§ããŸã. VSLãç«¶åä»ç€Ÿã«å¯Ÿãæåããªã¹ãã«ããŠããªãããšã以忹å€ããããšã§,ãã®çç¥ã¯å°ãç®èçã§ã. éè¡ ã¶ã»ããã¯ãšã¢ãã»ã¢ã³ã²ã« äž»ãªéèšããã¯"67æ³ã®éè·ããæåž«ãç¥çµçããªããããã«17以äžã®æ²»çã詊ã¿ãã,ãã£ãäžã€ã®ããšã广çã ã£ã"ã¯,ç¹æ®æ§ã¢ã³ã«ãŒãšçµã¿åããã ãã¿ãŒã³äžæãšããŠåäœãã.17å·ã¯,çŸå®æãæããã»ã©å ·äœç ("æ°åã®æ²»ç"ã§ã¯ãªã),ç²åŽãšä¿¡é Œæ§ã瀺ãã»ã©é«ã.ãããŠ,èŠèŽè ã®æªéã®å¯èœæ§ã®ããæŽå²ã«æ£ç¢ºã«å¹æµããã»ã©ã«éžæããã.ããã¯ã¯è£œåã«ååãäžã,䞻匵ããã,èŠèŽè ã«äœãããŠããªã.ææžåããã倱æã®ç©èªãžã®è§£æ±ºãçŽæãã.ããã¯,è³ãéãããããª,æãçŽç²ãªåœ¢åŒã§ãã open loopã®ç©èªã®ã®ã£ããã§ãã. åã«,ãã®ããã¯ã¯,ãã®è£œåã«ååãäžã,䞻匵ããã,äœãããããã«èŠæ±ãããããªã. ç¹å®ã®ç¶æ³ã«åãããŠ,ãã®æ©èœã¯,ãã®æ©èœã®æ¹åã«åœ¹ç«ã€. 2åéã®ããŒã¯ã®é å°å ¥ãããäºæ¬¡ããã¯æ§é ã¯",å¥åŠãªéŽäžããã¯"ãšãããã¬ãŒãºã§ãã£ã©ã¯ã¿ãŒã¹ããŒãªãŒããã¡ã«ããºã ãã¹ããªãŒãžãšç§»è¡ã,奜å¥å¿ã®ã£ãã ("å¥åŠ") ãšã¢ããªã±ãŒã·ã§ã³ã®èŠªå¯æ§ ("éŽäž") ãçµã¿åãããæå³çãªèªåœéžæã§ã.ããã¯,ãšãŠã²ã³ã»ã·ã¥ã¯ããã®æ çµã¿ã«ããã4段éã®åžå ŽæŽç·Žã®åãã§ã.ããã¯,è²·ãæã¯ãã¹ãŠã®çŽæ¥ããã,ãã¹ãŠã®"é©åœçå ¬åŒ"ãèŠãŠãã,çŸåš,ç¬èªã®è§åºŠã§æ°ããã¡ã«ããºã ã«ã®ã¿åå¿ããŠããŸã.VSLã¯ãã«ããŸã«ãé©åœçãšã¯åŒã°ãŸãã.ããã¯"æçµçã«ããªãã®ç¥çµã«å°éãã"補åãšåŒã°ããŠããŸã.ããã¯,以åã®è£œåã®å€±æãååŠã®åé¡ã§ã¯ãªãé éåé¡ãšããŠäœçœ®ã¥ããŠããããšãæ çµã¿åããŠããŸã. VSLã§èгå¯ãããäºæ¬¡çãªããã¯: - "ç¥çµã¯æã«1ã€ã³ããŸã§åçã§ããã,身äœã«é©åãªæ é€çŽ ãããå Žåã«ã®ã¿" - "ãªã³ã©ã€ã³ã§è²©å£²ããããµããªã¡ã³ãã®80%以äžã誀ã£ãã©ãã«ãå«ãã§ãã" (JAMAã®ããã¯ã»ã·ãŒãã¡ã³ã,æš©åšã ãã§ãªã) - "èã®è¶³å ã¯ç¥çµãé€ãããã®å šäœã®æè¯ã®ã²ãŒããŠã§ã€" - "ããªãã®äœã¯ãã°ãã·ãŠã ãäžžç¶ã®4ããŒã»ã³ãããåžåããªãã®ã§,ãããåãããã«ã¯"æ¥ã«40é ãå¿ èŠã«ãªã" - "å°çäžã§æãå¥åº·ãªäººã ã®ããæ¥æ¬ã§ã¯,äŒçµ±çãªå»åŠã¯å¿ é æ²¹ã«é Œã" ** ã¡ã¿ãYouTubeãã¹ãã®åºåã®ã¿ã€ãã«ã«å€æŽã¯:"17åã®å€±æããæ²»çã®åŸ,ç¥çµçã«å¹æã®ãããã®ãçºèŠããŸãã" - "ãªãããªããæåããŠãããã°ãã·ãŠã ãç¥çµã«å±ããªãã®ã" - "ããŒããŒãç ç©¶:ãã®1çš®é¡ã®ãã°ãã·ãŠã ã§ç¥çµçã87%æžãã" - "ã¬ããã³ãã³ãç¥çµç ãæ²»çããªãã£ãæ¬åœã®çç±,äœãèµ·ããã" - "圌女ã¯åç©åæ è¡ããã£ã³ã»ã«ããªããã°ãªããªãã£ã. 3é±éåŸ,ãã¹ãŠãå€ãããŸãã" éè¡ å¿ççèªçºãšèª¬åŸçç¥ Nervizol VSL ã®èª¬åŸåã®ããã¢ãŒããã¯ãã£ã¯,çã¿ãç·©åãããµããªã¡ã³ãã«ããŽãªãŒã®ã»ãšãã©ã®è£œåãããæŽç·ŽãããŠããŸã.æšæºç㪠åé¡-ã¢ã®ããã-ãœãªã¥ãŒã·ã§ã³ ã·ãŒã±ã³ã¹ãåç¬ã§è¡ãã®ã§ã¯ãªã,ãã®æåã¯è€æ°ã®èª¬åŸå±€ãç©ã¿éããããã·ãŒã±ã³ã¹ã«çµã¿åãããŸã.ã¢ã€ãã³ãã£ãã£ã®è åš (ããªãã¯ããäžçå€ããŠãã人éã§ã¯ãããŸãã),æš©é移転 (40幎éã®çµéšãæã€å»åž«ãæ¢ã«ãããããªãã®ããã«æ€èšŒããŠããŸã),瀟äŒèšŒæã®ã«ã¹ã«ãŒã (æåŸã«æšãŠãããã®ã§ã¯ãªã,å šäœã«ç¹ã蟌ãŸããŠãã7ã8ã€ã®èšŒèš),ãããŠ,æåŸã«,ã¢ã³ã«ãŒãªã³ã°ãšççž®ãéããŠäŸ¡æ Œå§çž®ã§ã.çµæã¯,売ã£ãŠãããããªæããæããªãæçŽã§ã.ä¿¡é Œã®ã¢ããã€ã¶ãŒãçºèŠã®ãããªæãã§ã.æ§é ãäœæããã广ã¯ãŸãã«å ±æã§ã. å ±æã¯,å ±æã®æè¡ã§ã. å ±æã¯,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§,ãã¹ãŠã®æ¹æ³ã§ ä¿èšŒäœç³»ã¯ç¹ã«æ³šç®ã«å€ãã.180æ¥è²šå¹£è¿æžä¿èšŒã¯,ã·ã¢ã«ãã£ãã¢èªã®æå³ã§ã¯ãªã¹ã¯ã®é転ã ãã§ã¯ãªã.ããã¯ã¿ã©ãŒã® æ©è³å¹æã®é©çšã§ãã.è³Œå ¥è ã補åãææãããš,è¿éããå¿ççãªã³ã¹ã (åªå,倿ãééããããšãèªããæèŠ,å°ããªç©æµæ©æŠ) ã¯,äžæºã®ããè³Œå ¥è ã®ã»ãšãã©ãè¿éãèŠæ±ããªãããšãæå³ããŸã.180æ¥éã®çªã¯,軜ãäžæºã®ããã»ãšãã©ã®è³Œå ¥è ãè¡åãèµ·ããåã«å¯å€§ã§æéåãããã®ã«ååãªé·ãããšã§ãã,æ§é çãªéžæãšããŠçè§£ã«å€ãã. - ãšããã¡ããŒããªããž (ã©ãã»ã«ã»ãã«ã³ãœã³,å°éå®¶ç§å¯): åè¿°è ã®ã¹ãªã©ã³ã«åºèº«ç©èª;å»åž«ãšããŠãã©ã³ãã£ã¢æŽ»åã,接波ã®å·ãããæ é€çŽ äžè¶³ã«ããç¥çµçã芳å¯ã,ååçºèŠã¯åæ¥çãªåæ©ã§ã¯ãªã,ç²åŸããæŽå¯åãšããŠäœçœ®ã¥ã,èŠèŽè ã®è²©å£²æµæãåçã«äœäžãããŠããŸã. - æå€±å«æª (ã«ããã³&ããŽã¡ãŒã¹ããŒ,1979): ã¹ã¶ã³ 㮠浪費 æ²»ç ã« ããã 3 äž ãã« ã¯,æåã® 90 ç§ ã« åãã£ãŠ ç©ãŸã£ãŠããŸã. æ²æ²¡ è²»çš æ çµ ã¯,æå€±å«æª ã æŽ»æ§åã,èŠèŽ è ã« Nervizol ã æ°ãã ãªã¹ã¯ ãš ã ㊠ã§ã¯ãªã, ãã® åé¡ ã 解決 ãã ãã ã« ãã§ã« çŽæ ã ã ㊠ãã è³é ã® æçµ ç 㪠æ£ç¢º 㪠å²ãåœãŠ ãš èŠã ãã ä¿ããŸã. - åœãã®æµã®ãã¬ãŒã (ã¯ã©ã·ã㯠VSL ã³ãã©ã€ãã£ã³ã°,ãã©ã³ã¯ã»ã«ãŒã³ã®è¡çµ±): è£çµŠç£æ¥,誀ã£ãæšèä»ã補å,ãããŠå®ããã°ãã·ãŠã é žåç©ã®åœ¢åŒã¯,æ¬ç©ã®JAMAãšFDAã®åŒçšã«ãã£ãŠæ¯æãã,ãã«ããŸã«ã®å«ççãªå€åŽãšããŠã®äœçœ®ä»ãã¯,èªå·±å¥ä»ã§ã¯ãªãä¿¡é Œæ§ã®é«ãããã«æããŸã. - æš©åšã®ç©ã¿éã (Cialdini,1984幎,æš©åšåå): èªãæã¯ããŒããŒãé¢é£ç ç©¶,ããšã¯ãªããã¯ã®ç ç©¶,JAMAã®çºèŠ,FDAã®èª¿æ»,ããã³40幎éã®å人çãªå®è·µã次ã®åŒçšã匷åããããã«èšèšããé åºã§åç §ã,åäžã®åŒçšããã倧ããªçޝç©çãªä¿¡é Œæ§å¹æãçã¿åºããŸã. - 瀟äŒèšŒæã«ã¹ã«ãŒã (Cialdini, Social Proof; Festinger's social comparison theory): ååä»ãã®èšŒèš (Linda, Kim) ã¯åæã®ç©èªãæ¯ããäžæ¹,å¿åçãªèšŒèšã¯VSLã®åŸåã«é åžãã,èŠèŽè ã粟ç¥çã«å²åŒã§ããåäžã®ãããã¯ã§ã¯ãªãçŽ2ã3åããšã«æ°ãã瀟äŒèšŒæãééããããšãä¿èšŒããŸã. - èªæäŸ¡æ Œ (å ã»ã©,äºæž¬å¯èœã«éåçç,2008): ç¶ããã79ãã«,69ãã«,49ãã«ã®3å±€ã¯,ã¯ã©ã·ãã¯ãªèªææ§é ãšããŠæ©èœãã.äžéãªãã·ã§ã³ã¯äž»ã«6ç¶ã»ãããæ¯èŒããŠåççã«æãããããã,äžè²«ããŠæã䟡å€ã®é«ããã³ãã«ã«åãã£ãŠè²·ãæã®è¡åãå€åãããæšæºçãªã¢ã³ã«ãŒè£ 眮ã§ã. - ãã¹ããªãŒããŒãã¹ (奜å¥å¿ã®ã£ãã + è³äžå¹æ): è³Œå ¥åŸã®ã¿æããã«ãªã£ã"1200ãã«äŸ¡å€ã®ãµãã©ã€ãºãã¬ãŒã³ã"ã¯åŒ·åãªã³ãããã¡ã³ãè£ çœ®ã§ã.ããã¯è²·ãæã«æåŸ ã§ãããã®ãäžã,売ãæããååã®æ§è³ªãäºåã«æããã«ããå¿ èŠãªãã«èªèãããæ³šæäŸ¡å€ãå¢å ãã,ãã¬ãŒã³ããåãåãå¿ççãªçŸ©åãçã¿åºããŸã.ããã¯æ³šæãç¶æããå¿ èŠããããŸã. > å»çè£çµŠåéã«ããã 50以äžã® VSLã« ãã®æŠè¡ãã©ã®ããã«æ¯èŒãããããç¥ãããã§ãã? ãŸãã«Intel Servicesã瀺ãç®çã§ã éè¡ ## ç§åŠçã»æš©åšçä¿¡å· VSLã®æš©åšã€ã³ãã©ã¹ãã©ã¯ãã£ã¯è€éã§åè§£ã«å€ãã.èªãæã¯"40幎以äžã®å®ç¿ãæã€ã¢ã¡ãªã«ã®ãããå»åž«"ãšããŠèªåèªèº«ãèšè¿°ãã.ã¬ã³ãŒãã£ã³ã°ã§ã¯,圌ãæç€ºçã«ãªãºå士ãšããŠååã§ã¯ãªã,ãã¬ãŒã ãªã³ã°ãèšèŒããŠãã.ã»ã¬ããã£ã»å»åž«ã®æ§æ Œ,劻ã®ãœãŒã·ã£ã«ãããã¯ãŒã¯,ã¹ãªã©ã³ã«ã®ãã©ã³ãã£ã¢èæ¯;ã¡ã¡ã¡ããã»ãªãºã®å ¬çæ§æ Œã坿¥ã«è¿œåãã.çŽæ¥å±æ§ãªãã«èªèå¯èœãªå ¬ã®æé»ã®ã¢ã€ãã³ãã£ãã£ã䜿çšããããšã¯,VSLãæè¡çåŠå®æ§ãç¶æããªãã,ã»ã¬ããã£ã®ä¿¡é Œæ§ãæç²ããããšãå¯èœã«ããæ³çæäœã§ã.èªè ã¯ãã®æ§é ãæèããå¿ èŠããããŸã. å»åŠåŒçšã¯åæ³ããæ€èšŒã§ããªããã®ãŸã§ã§ã. åšèŸºç¥çµåçç (æ1ã€ã³ããŸã§) ã«ã€ããŠã® Mayo Clinicã®äž»åŒµã¯,åšèŸºç¥çµçç©åŠã«é¢ããåºçç©ãšäžèŽããŠãã,ããã¯å®æ çã§ããææžåãããçŸè±¡ã§ã. 誀æšé ããããµããªã¡ã³ãã«é¢ãã JAMAã®åŒçš ("ãªã³ã©ã€ã³ãµããªã¡ã³ãã®80%以äžãäžæ£ç¢ºãªã©ãã«ãå«ãã§ããŸã") ã¯,å®éã®æžå¿µãææããŠããŸã. FDAã¯èª€ã£ããµããªã¡ã³ãã«é¢ãã倿°ã®èŠåæžç°¡ãçºè¡ããŠãã, JAMAã¯ãµããªã¡ã³ãã©ãã«ã®æ£ç¢ºæ§ã«é¢ãã調æ»è«æãçºè¡šããŠããŸãã,ãã®åæã®æºåäžã«ç¹å®ã®å ¬è¡šãããç ç©¶ã«äžèŽããããšãã§ããªãã£ã.確èªãããèªè ã¯,çŽæ¥ ãžã£ãŒãã«ã»ãªãã»ã¢ã¡ãªã«ã³ã»ã¡ãã£ã«ã«ã»ã¢ãœã·ãšãŒã·ã§ã³ã®ã¢ãŒã«ã€ããŸã㯠FDAã®èŠåæžç°¡ããŒã¿ããŒã¹ãæ€çŽ¢ããå¿ èŠããããŸã. æãéèŠãªæš©åšäž»åŒµã¯,ãã°ãã·ãŠã ã¯ãã©ã€ãã䜿çšãã3000人ã®ãã©ã³ãã£ã¢ã§ç¥çµçã®87%æžå°ã瀺ãã**ããŒããŒãé¢é£å»çã»ã³ã¿ãŒ2023ã®ç ç©¶ã§ãã.ããã¯ç¹å®ã®æ©é¢ã¿ã€ã,幎,ãµã³ãã«ãµã€ãº,ããã³çµææ°ã§,æ£åœãªèšåºè©Šéšãæ€èšŒå¯èœãªå ¬å ±èšé²ãæ®ããããªéåžžã«å ·äœçãªäž»åŒµã§ãã.ãã®ç ç©¶äžã«ClinicalTrials.gov,PubMed,ãŸãã¯ããŒããŒãé¢é£æ©é¢ããŒã¿ããŒã¹ã«äžèŽãã詊éšãèŠã€ãããŸããã§ãã.ããã¯ç ç©¶ãååšããŠããªãããšã決å®çã«èšŒæãããã®ã§ã¯ãããŸããã,æœåšçãªè³Œå ¥è ã¯ãã®æ°åãç¬ç«çã«æ€èšŒãããç§åŠãšããŠæ±ããªããã°ãããŸãã.ããã¯å®éã®æªå ¬éã®æ¥çç ç©¶,誀ã£ãçºèŠ,ãŸãã¯æé ãããçµ±èšåŠã§ãã,åºå¥ãå¯èœã§ã. æ¥æ¬äŒçµ±å»åŠã®åèæç® ("å°çäžã§æãå¥åº·ãªäººã ã®äžéšãæããå®¶") ãšåžåçæ¯èŒ (æ²¹ã¯97%ãšé å€ã¯40%) ã¯æ¹åçã«åççã§ãã,ãœãŒã¹ãªãã§æç€ºãããŠããŸã.æ¥æ¬ã®äººå£ã®é·å¯¿ã¯å®åšçã§ããææžåãããŠããŸã.ç¹ã«å¿ é æ²¹ã®äœ¿çšã«é¢é£ä»ããããšã¯,éèŠãªéæ¯æçæšè«çãªè·³èºã§ã.åžåçã®æ°åã¯å®æ°çãªç§åŠç宿°ã®ããã«æç€ºãããŠããŸã.å®éã«ã¯åžåçã¯åå,ç®èã®å Žæ,é æ¹è»äž¡,ããã³åã ã®ççåŠã«ãã£ãŠéåžžã«ç°ãªããŸã. éè¡ äŸ¡æ Œ ãªã¹ã¯ é転 Nervizolã®äŸ¡æ Œèšå®ã¯,èšèšçã«è¯å¥œã§ã.ããã«ããã118ãã«ãšãã宿å°å£²äŸ¡æ Œãåºæºç¹ã確ç«ã,3ã€ã®éå±€ããã±ãŒãžã¯79,69ãã«,49ãã«ã§ã.çŸåšã®ç¯çŽã¯ãããã33%,42%ããã³58%ã§ã.49ãã«ã§6ããã«ãªãã·ã§ã³ã¯75%å²åŒã§æ ä»ããããŠããŸã.ã€ãŸã6ããã«ã®å®å šãªå°å£²ã¹ã¿ãã¯ã708ãã«ã«ãªããŸã.294ãã«ã®è³Œå ¥ã¯éèŠãªçµæžçåå©ã®ããã«æããŸã. äŸ¡æ Œã¢ã³ã°ãªã³ã°ã¯åæ³çã« (補åã®ç¬èªã®å°å£²äŸ¡æ Œã«åºæºå€ä»ã) ãšèšè«çã« (300ãã«ã®å»çã¹ããŒã¹ã«åºæºå€ä»ãã,环èšã«å€±æããæ²»çæ³ã§3,000ãã«ã«èšå®ãããŠããŸã. 6ç¶ã»ããã®ããŒãã¹æ§é ã¯,æå€§è³Œå ¥ãå¯äžã®åççãªéžæã«ããããã«èšèšãããŠããŸã.120ãã«ã«äŸ¡å€ã®ãã3åã®é»åæžç±,1,200ãã«ã«äŸ¡å€ã®ããè¬ã®èŽãç©,ããã«75%ã®å²åŒ.ç©ã¿éããããèªè䟡å€ã¯,å°èŠæš¡ãªè³Œå ¥ãããŒãã«ã«ãéãæ®ããããªæèŠãäžããããã«,294ãã«ã®èŠæ±äŸ¡æ ŒãäžåããŸã.è¬ã®èŽãç©ã¯ç¹ã«è³¢ãã¡ã«ããºã ã§ã.ãã®æªé瀺æ§ã«ãã,1,200ãã«ã®è©äŸ¡ã¯çåèŠããã,åãåãäºæã¯,泚æå®äºçãå¢å ãã,è¿éèŠæ±ãæžããã³ãããã¡ã³ãããã€ã¹ãšããŠæ©èœããŸã. è¬ã®èŽãç©ã¯,ç¹ã«è³¢ãã¡ã«ããºã ã§ã. è¬ã®èŽãç©ãšã¯,æããã«ãããŠããªãæ§è³ªã«ãã£ãŠ,1,200ãã«ã®è©äŸ¡ãçåèŠãã,åãåãäºæã¯,泚æå®äºçãå¢å ãã,è¿éè«æ±ãæžå°ããããããªã³ãããããã€ã¹ãšããŠæ©èœããŸã. è¬ã®ãã¬ãŒã³ãã¯,æãéèŠãªèŠçŽ ãšããŠ,æãéèŠãªèŠçŽ ãšããŠ,æãéèŠãªèŠçŽ ãšããŠ,æãéèŠãªèŠçŽ ãæ§æãã,ããªãã¡,ãã¹ãŠã®ååã®äŸ¡æ Œãèšå®ãã. 180 æ¥ä¿èšŒã¯æ¬æ Œçã«æ¬æ Œçãªãã®ã§,6ã¶æã¯,æ¶è²»è ã®ä¿è·ãæå³ã®ãããã®ãšããéäžè¬çãªé·ãçªã§ãã,ä¿¡é Œæ§ã®èšŒæãšããŠãã®æ çµãèšãã ("ããã»ã©èªä¿¡ããã") ã¯,ãã®è£ã«ãã忥çè«çãé®ããŸã.æ¶è²»åã«ããã»ã©é·ãä¿èšŒã¯,ä¿èšŒæéã¯äœ¿çšæéå šäœãã«ããŒããããšãæå³ã,äŸçµŠãå®äºãããŠãŒã¶ãŒã«ãšã£ãŠçè«çã«å¯èœã§ããã,å®è³ªçã«çãããã®ãšãªã.ç·æ¥ã®æ çµ ("52ç¶æ®ã£ãŠãã","æ°æ¥ã§è²©å£²ãããæåŸã®3匟") ã¯æšæºçãªè£œé äžè¶³ã§ãã,è²·ãæã¯ãã®å¿ããé©åã«æ ¡æ£ããå¿ èŠããããŸã.ãã®æ°åã¯ã»ãŒç¢ºå®ã«ãããªã§éæ¢ã§,ãªã¢ã«ã¿ã€ã ã€ã³ãã³ããªããªããžãåæ ããŠããªã. ãããªã§ã¯,ãã®æ°åã¯ã»ãŒç¢ºå®ã§ã. ãããªã§ã¯,ãã®æ°åã¯,ã»ãŒåºå®ã§ã. ãããªã§ã¯,ãã®æ°åã¯,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã®æéã§,å®éã® éè¡ ã©ãã«ããã®ã çæ³çãªãã«ããŸãŒã«è³Œå ¥è ã¯,VSLã®èªäœã®ãã¬ãŒã ã¯ãŒã¯ãšè£œåã®ã¡ã«ããºã ã«åºã¥ããŠ,50代åŸåãã70代åã°ã®åšçžç¥çµç ç,ç¹ã«è¶³ãšäžè¢ã§,æºè¶³ã®ããè§£å床ãªãã«åŸæ¥ã®æ²»çã®è€æ°ã®ã©ãŠã³ããçµãŠæç¶ããæäººã§ãã.ç³å°¿ç ç¥çµç æ£è ã¯,æç¢ºãªæšçãšãªãéèŠãªãµãã»ã°ã¡ã³ãã§ãã.è³Œå ¥è ã®äž»èŠãªåæ©ã¯æœè±¡çãªçã¿ç·©åã§ã¯ãããŸãã.ããã¯ç¹å®ã®ç掻äœéšã®å埩,å€é£ã調ç,å€äžã«ç ã,å«ãšä»ãåãããš,ç¥çµç çãå°é£ãŸãã¯äžå¯èœã«ãã.ãã®è³Œå ¥è ã¯çµæžçã«ãæ éã§ã (æªéæ²»çã®æ²æ²¡ã³ã¹ããã©ãã£ãã¯åœŒãã®çµéšããå ±é³Žãã),ææ çã«ç£šãæã,ãããŠæ°ãããã®ã«å¯ŸããŠçã«ãªãŒãã³ã§ã.ããã,ç°ãªãè¡åã¡ã«ããºã ãå¯èœã§ã. ãã®è³Œå ¥è ãããã£ãŒã«ã§ã¯,補åãåççãªãªã¹ã¯èª¿æŽè©ŠéšãæäŸããŠãã. 180 æ¥ä¿èšŒã¯,çµæžçãªã¹ã¯ãå¶éãããŠããããšãæå³ã,ç®è代è¬ã¢ãããŒãã¯,壿è£çµŠåããçã«åºå¥ãã,äžæåé æ¹ (ãã°ãã·ãŠã ã¯ããªã,MSM,ã¢ãã«) ã¯,ç¹å®ã®ç®è代è¬ç¥çµç ã®èšŒæ ãèãå Žåã§ãäžè²«ããè¬çåŠçè«çãæã£ãŠããŸã.çµæãªãã«å£æãã°ãã·ãŠã ã詊ãã人ã¯,ç®è代è¬åœ¢åŒã詊ã確åºããçç±ããã,ã·ã¹ãã çãªè¬ç©çžäºäœçšããªããã,å€ãã®åŠæ¹è¬ä»£æ¿åããã,ããã«ã«ãã°ãã·ãŠã ãæå³çã«å®å šã§ã. çç¶ç®¡çãããæ²»çãåžæããè³Œå ¥è :VSLã¯"éç¥çµæå·"ã®èšèªã䜿çšã,é«åºŠãªç¥çµç çã®å Žå,ã©ã®åœå補åã§ãéæã§ãããã®ãã»ãŒç¢ºå®ã«èªåŒµããŠãã.ç¥çµç ãä¿®æ£å¯èœãªæœåšåå (B12æ¬ ä¹ç,ç²ç¶è ºæ©èœäžå š,è¬ã«ããç¥çµç ç) ãæã€è³Œå ¥è ,ãã®æ ¹æ¬åå ãå»åž«ã«å°ããã¹ãã§ãã,ãã®åšãã«è£å®ããããããã.ãããŠ,äž»ã«æåãªå»åž«ã®æ çµã¿ãããŒããŒãç 究䞻匵ã«ãã£ãŠåŒãå¯ããããŠããè³Œå ¥è ,決å®ããåã«ãããã®èŠçŽ ãæ€èšŒãããèšåºæ¿èªãããããŒã±ãã£ã³ã°ã¢ãŒããã¯ãã£ãšããŠèªèãã¹ãã§ã. 決å®ããåã«,ãããã®èŠçŽ ãè©äŸ¡ããå¿ èŠããããŸã. > ãã®åé¡ã圹ã«ç«ã€ãšã¿ãã°,ã€ã³ãã«ãµãŒãã¹ãå¥åº·è£çµŠ,éè,å人éçº VSLã«ããŽãªãŒã«äŒŒããããªåæãå ¬éããŠããŸã.äžèšã® [å¿ççè§Šçºæ©ã»ã¯ã·ã§ã³] éè¡ ## ãããã質å Q:ãã«ããŸã«ã¯è©æ¬ºã§ãã? A:ãã«ããŸã«ã¯, 8ã©ãã販売ããŠããå®è£œåã§,æ€èšŒå¯èœãªééæ¿çããã,çŽæ¥çãªè©æ¬ºã®ã«ããŽãªãŒããå€ããŠãã.ããã,VSLã«ã¯ããã€ãã®æªç¢ºèªã®æš©åšäž»åŒµãå«ãŸããŠããŸã.ç¹ã«,远跡å¯èœãªåºçç©ããªããšåŒçšãããããŒããŒãé¢é£ç ç©¶ã§ã.ãããŠ,補é ãããçšä¹æ§ãšã»ã¬ããã£ã»å»åž«ã®æ§æ Œãæœåšçãªè³Œå ¥è ãæ¹å€çã«è©äŸ¡ãã¹ãæ¹æ³ã§äœ¿çšããŸã.補åã®ã³ã¢æå (ãã°ãã·ãŠã å¡©åç©,MSM,ã¢ãã«) ã¯,ç¹å®ã®ç®èç¥çµç ã®äž»åŒµãå ¬è¡šããã蚌æ ãããå è¡ã§ãã£ãŠã,æ£åœãªç§åŠçè£ä»ããæã£ãŠããŸã. Q:ãã«ããŸã«ã¯ç¥çµç ã«æ¬åœã«å¹ãã®ã? A:çãã¯"åã"ã®æå³ãã倧ããç°ãªããŸã.åœæã®ãã°ãã·ãŠã ã¯ããŒãã¯åºæ¿ç¥çµç«¯ã«å±æçãªé®é广ãäžããããšãã§ã,MSMã¯æçæ§ç¹æ§ã瀺ããŠãã,çç¶ç·©åã¯çç©åŠçã«åççã§ãã.VSLã«ãã£ãŠäŒŽãçã¿ã87%æžããã,æ§é ç¥çµä¿®åŸ©ã¯,çŸåšã®ç¬ç«ãã蚌æ ãæããã«æ¯æããŠããªãã¯ããã«é«ãããŒã§ã.åã ã®çµæã¯,倧ããç°ãªãå¯èœæ§ããã,180æ¥ä¿èšŒã¯èªå·±æ€æ»ã®ããã®åççãªçªå£ãæäŸããŸã. 詊éšã¯,éåžž,éåžž,éåžž,éåžž,éåžž,䜿çšããããã®ãšããŠäœ¿çšãããŸã. Q: Nervizol ã®å¯äœçšã¯ã©ã®ãããªãã®ã§ãã? A: VSL ã¯,説æããã䜿çšè éã§éå€§ãªæå®³å¹æã瀺ããŠããªããã,åœæã®ãã°ãã·ãŠã ã¯ããªãã¯äžè¬çã«ã¯ã»ãšãã©ã®æäººã«ãšã£ãŠå®å šã§ãããšèªèãããŠããŸã.é©çšå Žæã§ã®è»œåºŠã®ç®èåºæ¿ãæãå«ãå¯èœæ§ããããŸã.ãã°ãã·ãŠã 油補åã§ã¯äžè¬çã§ã.è èçŸæ£ã®äººã¯,ãã°ãã·ãŠã 補åã䜿çšããåã«å»åž«ã«çžè«ããå¿ èŠããããŸã.è èã®é害ã«ãã,éå°ãªãã°ãã·ãŠã ã广çã«é€å»ããããšãã§ããŸãã. VSL ã¯ãã®å察æç€ºã瀺ããŸãã. ** Q: Nervizol ã¯ç³å°¿ç ç¥çµç ç ã« å®å š ã. A: ã㮠補å 㯠ç³å°¿ç ç¥çµç ç ã® æ£è ã« ç¹å¥ 㫠販売 ã ã ㊠ã ãŸã.ãã® æå ã« ã¯,ç³å°¿ç è¬ ãš ã® é¢é£ ã« é¢é£ ã ㊠åé¡ ç 㪠çžäºäœçš ã ç¥ã ã ㊠ãã ç©è³ª ã å«ãŸã ㊠ã ãŸã ã.ããã,ç³å°¿ç ç¥çµç ç 㯠ã·ã¹ãã ç ãª ç¶æ ã® éç ã§ã.ãã ã 广ç㫠管ç ãã ãã ã« ç¶ç¶ ç 㪠å»ç ç£ç£ ã å¿ èŠ ã§ã. Nervizol 㯠å»ç æ²»ç ã« è£å® ã ㊠çç¶ ç·©å ã æäŸ ã ㊠ã ãŸã.åŠæ¹ ã ã ã æ²»ç ã è¡ç³ 管ç ã 眮ãæãã ã¹ã 㧠㯠ãªã. Q:ãã«ããŸãŒã«ãå¹ãã®ã«ã©ããããæéããããã®ã A:VSLã¯,äžéšã®ãŠãŒã¶ãŒãæåã®æäžãã15å以å ã«ç·©åãæãããšäž»åŒµããŠãã,ã»ãšãã©ã®èšŒèšã§ã¯2ã4é±é以å ã«ææçŸ©ãªæ¹åãèšè¿°ããŠããŸã.æç¶çãªçµæã®ããã«æšå¥šãããå®å šãªæ²»çã³ãŒã¹ã¯3ã6ã¶æã§ã.ãã°ãã·ãŠã 貯èµãšç¥çµä¿®åŸ©ã¯æç¶çãªè£çµŠãå¿ èŠãšãããšããè°è«ã«åºã¥ããŠããŸã.ãããã®æé軞ã¯,ãã°ãã·ãŠã ããŒã¹ã®æççæ§åœæ¥è¬ããæåŸ ã§ãããã®ãšäžèŽããŠããŸãã,ãã®ç¹å®ã®é æ¹ã«ããäœçšã®éå§ã«é¢ããç¬ç«ããèšåºããŒã¿ã¯å ¬éãããŠããŸãã. Q: Nervizol ã® ã©ãçš ã® ããã« ã æ³šæ ãã ã¹ã ã§ã ã. A: VSL ã¯ äŸ¡æ Œ èšå® ãš ããŒãã¹ã® çç± ã« ã㣠㊠6 ããã« ã® ããã ã åŒ·ã æŒãä»ã ㊠ã ãŸã.çŽç² 㫠補å ã® äœ¿çš ã® èŠ³ç¹ ãã, 2 ããã« ã¯ çŽ 2 ã¶æ ã® äœ¿çš ã æäŸ ã ㊠ã ãŸã.ãã ã¯,補å ã å€§èŠæš¡ ãª è³Œå ¥ ã ããããšã« ã³ããã ãã å ã« æå³ ã® ãã ç·©å ã æäŸ ã ㊠ãã ãåŠãã è©äŸ¡ ãã åå㪠ãã® ã§ã. 180 æ¥ ã® ä¿èšŒ ã èæ ® ã ãŠ, å€§èŠæš¡ 㪠ããã ã æ³šæ ãã ããš ã¯ çµæžç ä¿è· ã åã ㊠ã ãŸã.ããã,ãã å°ãã é ã éå§ ãã ãš ã¯, $ 294 ã è²»ã ãã å ã« å人 ç 㪠åå¿ ã è©äŸ¡ ãã ã® ã« éã,æ é ãª è²·ãæ ã㡠㫠㯠åç ç ãª æ¹æ³ ã§ã. Q: Nervizol ãã©ãã§è³Œå ¥ã§ããŸãã? A: VSL ã« ë°ë¥Žë©Ž,Nervizol 㯠8 Labs ã®ãã¬ãŒã³ããŒã·ã§ã³ããŒãžãéããŠã®ã¿å ¥æå¯èœã§ãã,ç©ççãªåºèãã¢ããŸã³ãªã©ã®ç¬¬äžè ã®å°å£²åºã§ã¯è²©å£²ãããŠããŸãã. VSL ã¯ãããåœç©ã®é²æ¢ã®ããã®å質管çã®ææ®µãšããŠåãäžããŠããŸã.ããã¯æ¬ç©ã®ãã®ãããããªãã,äŸ¡æ Œæ¯èŒã鲿¢ã,販売ã®ãå¶åŸ¡ããããã®æŠç¥ãããããŸãã.è³Œå ¥è ã¯çŸåšã® 8 Labs ã®å ¬åŒãŠã§ããµã€ãã§ã¢ã¯ãã£ããªãŒããŒããŒãžãæ€çŽ¢ããå¿ èŠããããŸã. Q:VSLã¯ãã«ãŽã£ãŸãŒã«ãšã®é¢é£ã¯çŸå®ãªã®ã? A:VSLã¯èªãæãDr. Ozãšæç€ºçã«åœåããããšã¯ãããŸããã,40幎å®åã®æåå»ã§ããããŒãœããæ§ç¯ããŠããŸã. "ã¢ã¡ãªã«ã®ãããå»åž«ã®äžäºº"ãšåŒã°ããã»ã©æåã§ã.ãã®é¢é£ã匷ãæç€ºããŠããŸã.VSLã®ãã£ã©ã¯ã¿ãŒã¯èªãæã«çŽæ¥"Dr. Oz"ãšèªããããŠããŸã.ããã¯å ¬ã®å®çžŸã®æ¿èª,ããŒãœãã®äœ¿çšèš±å¯,ãŸãã¯æªæ¿èªã®å²ãåœãŠãæ§æããŠãããã©ããã¯VSLããæããã§ã¯ãããŸãã.ãããŠè³Œå ¥è ã¯,ç¬ç«ããæ€èšŒãªãã«æ¬è£œåãå人çã«ãã¹ããŸãã¯æ¿èªããæ¬ç©ã®åå»ããããšä»®å®ãã¹ãã§ã¯ãããŸãã. éè¡ # # æåŸã®æ±ºå® Nervizol VSLã¯,ã«ããŽãªãŒå¹³åãããé«åºŠãªã¬ãã«ã®äžã§ã®å¥åº·è£çµŠåã®ããŒã±ãã£ã³ã°ã§æ©èœãã,å·§ã¿ã«æ§ç¯ããã補åã§ã.æ é€çŽ ã®é éã¡ã«ããºã ãæ é€çŽ ãã®ãã®ãšåããããéèŠã§ãã,åœé¢è·¯ã¯å£æè·¯ã®åžåé害ãåé¿ãããšããæ žå¿æŽå¯ã¯,補é ãããŠããŸãã.ãã°ãã·ãŠã ã¯ãàš°àšŸàšãã¯,å®éã®æ§è³ªãæã€å®éã®æåã§ã.MSMãšã¢ã«ãã«ã¯,å®éã®,ãããç©ãããªèšåºæç®ã«ãã£ãŠè£ä»ããããŠããŸã.ãããŠåšèŸºç¥çµç ã¯,è¬å€ã®ããŒã«ãããã«ãã£ãŠçã«äžè¶³ããŠãã.補åã®åºæ¬çãªææ¡ã¯éŠ¬é¹¿ããªãã,ä»ã®ã©ãŠã³ãã®ã¬ãããã³ãŸãã¯ç¬¬äžã®ç¥çµãããã¯ã®ä»£æ¿åã§ããè³Œå ¥è ã«ãšã£ãŠ,180æ¥ä¿èšŒãããåœé¢æ²¹è©Šéšã¯äžåççãªæ±ºå®ã§ã¯ãããŸãã. VSLã¯,äžç¢ºå®ãªç§åŠãäºå®ãšããŠå è£ ãã. 87%ã®çã¿ã®è»œæžã®æ°å,ããŒããŒãé¢é£ç ç©¶,æ²¹ã®åžåç97%ã¯,æãããèŠãããå Žå,åæçºèŠ,æ¥çãæ¯æŽããããŒã¿,ãŸãã¯æ¹åæ§é¡äŒŒæ§ã§ãããšãã«ç¢ºç«ãããå»åŠçãªåæã®ä¿¡é Œæ§ã§æç€ºãããŠããŸã.補é ãããçšä¹ (52ç¶ãæ®ã£ãŠãã,äºåã«é²é³ããããããª) ãšæé»ã®ã»ã¬ããªãŒã»ãšã³ãœã³ãã¡ã³ã (Dr. Ozã¯å®å šå±æ§ãªãã«å±é) ã¯æšæºçãªçŽæ¥åå¿ã®å¿«é©ãªæŠè¡ã§ãã,圌ãã¯èãæ·±ãæ¶è²»è ãäžå¿«ã«ããæãå¯èœæ§ã®ããèŠçŽ ã§ããããŸã. VSLã¯,ãã®èг客ã以åçããããŠããããšãæç¢ºã«ç¥ã£ãŠããŸã.ãããŠ,ããã¯,ç³æ²¹ãå®å šã«æ€èšŒã§ããªãæš©åšã«å åäŸåããŠããéã«,ç³æ²¹ãæç¢ºã«åºå¥ããããã«ååãªå®ç§åŠãçŽæ¥å±éããŠããŸã. ãã®VSLãæçµçã«åžå Žã«ã€ããŠæããã«ããŠããã®ã¯:ç¥çµçæ³ã®è£çµŠã¹ããŒã¹ã¯,èªåã®ç¶æ ã«ã€ããŠç¥ã£ãŠã㊠(Lyrica ãšã¢ã«ãã¡ãªãé žãšã¯äœããç¥ã£ãŠãã) çµéšè±å¯ãªè²¡åçã«å€±æãã (æ°åãã®ãéãè²»ããã) é¡§å®¢ã§æºããããŠããããšã§ãã,åçŽãªå©çè«æ±åºåãéããŠèŠãã»ã©ææ çã«æŽç·Žãããããšã§ãã.ãã®ã¯ãªãšã€ãã£ãããŒã ã®åå¿ã¯,æåã®8åé,補åããŸã£ãã宣äŒããªãæçŽãæ§ç¯ããããšã§ã.ãã®åæã¯,èŠèŽè ã«äŒŒãŠãããã£ã©ã¯ã¿ãŒã§äžçãæ§ç¯ã,ãããèŠèŽè ããã§ã«åãå ¥ããŠããç©èªã®ç²åŸããçµè«ãšããŠè£œåã«æç€ºããŸã.ããã¯åççãªæšæºã§å 鲿®µéã®ã³ããŒã©ã€ãã£ã³ã°ã§ãã,ãããèªèããããšã¯,ãã®åæããŸã è³Œå ¥ãããã©ãããæ±ºå®ããèªè ãæãæçšãªãã®ã§ã. èŠèŽè ã¯ãŸã è³Œå ¥ããŠããªããã©ãããæ±ºå®ãã. èŠèŽè ã¯,ãã®ååãè³Œå ¥ãããšãã«,ãã®ååãè³Œå ¥ãããšãã«,ãã®ååãè³Œå ¥ãããšãã«,ãã®ååãè³Œå ¥ãããšãã«,ãã®ååãè³Œå ¥ãããšãã«,ãã®ååãè³Œå ¥ãããšãã«,ãã®ååãè³Œå ¥ãããšãã«,ãã®ååãè³Œå ¥ãããšãã«,ãã®ååãè³Œå ¥ãããšãã«,ãã®ååãè³Œå ¥ãããšãã«,ãã®ååãè³Œå ¥ãããšãã«,ãã®ååãè³Œå ¥ãããšãã« ãã®åé¡ã¯,å¥åº·,éè,å人éçºã«ããŽãªãŒãã«ããŒããVSLãšåºåã³ããŒåæã®ç¶ç¶çãªã©ã€ãã©ãªã§ããIntel Servicesã®äžéšã§ã.é¡äŒŒã®è£œåãæ¢ããŠããå Žåããã®é åã§èª¬åŸã¢ãŒããã¯ãã£ãã©ã®ããã«æ©èœãããçè§£ããããšããŠããå Žåã¯,èªã¿ç¶ããŸã. éè¡ å 責: ãã®èšäº 㯠ç ç©¶ ã æè² ã® ãã ã« éã ãã® ã§ã.å»åŠ,æ³,è²¡æ¿ ã® å©èš 㧠㯠ãã,補å ã ã㮠補é è ã« é¢é£ ã ㊠㯠ãã ãŸã ã.å¥åº· ã è²¡æ¿ ã® æ±ºå® ã ãã å ã«,åžžã« è³æ Œ ã åãã å°éå®¶ã« çžè« ã ㊠ãã ãã.
Comments(0)
No comments yet. Members, start the conversation below.
Related reads
- DISreviews
NerveSync VSLãšåºååæ
ãããªã¯ åå Žã忢ãããã»ã© èŽ æ²¢ãªçŽæã§å§ãŸããŸã ã¢ã¡ãªã«è»ãåŒãã§ããç· æ©å¯ãªå ¬åŒ ãã㊠補åã倱æããã 芳客ã«å€¢ã®å®¶ãæäŸãããšããææ¡ã§ã
Read - DISreviews
ãã¬ããããã¯ã¬ãã¥ãŒãšåºåã®åè§£:ç ç©¶ååèŠ
女æ§ã®å£°ã§å§ãŸãçãåç»ã¯ "諊ããããšãã"ãšãããã®ã§ã 圌女ã¯é£ã¹ãå šãŠã®é£äºã æ¶æ¯ã®ææ±ã éåã...
Read
reviewsã¢ãªã³ã¬ãžã§ã€ã³ã ã¬ãã¥ãŒ ãš åºå åé : ç ç©¶ ã® åã ã® èŠæ¹
ãããªã¯æå³çã«è§£äœããçŽæã§å§ãŸããŸã æè¡ãåŠæ¹ç®ã è£çµŠåã ãããŸãã èãšçŸå®¹æ¶²ã ãã§ã
Read